# Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

> **NCT04417218** · NA · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 67 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Lysine
- **DIETARY_SUPPLEMENT:** Controlled Diet

## Key facts

- **NCT ID:** NCT04417218
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-17
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04417218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04417218, "Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04417218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*